LEAF - TSLA MRNA among premarket gainers August, 12 2020 08:19 AM Leaf Group Ltd. EyeGate Pharmaceuticals (NASDAQ:EYEG) +35% on development path for conjunctivitis treatment.More news on: EyeGate Pharmaceuticals, Inc., Cellular Biomedicine Group, Inc., Vascular Biogenics Ltd., Stocks on the move, , Read more ...